期刊文献+

CYP1A1和CYP2E1基因多态与胃癌易感性关系的研究

Research on Association of Genetic Polymorphism of CYP1A1 and CYP2E1, with Susceptibility to Gastric Cancer
下载PDF
导出
摘要 目的:探讨细胞色素P450 (CYP450)基因CYP1A1第7外显子的Ile462Val (rs1048943)以及CYP2E1-1239G>C (rs3813867)单核苷酸多态(SNP)与胃癌遗传易感性的相关关系。方法:采用病例–对照研究,聚合酶链反应–限制性片断长度多态性分析(PCR-RFLP)方法,分析230例胃癌患者和460例正常对照者的CYP1A1基因Ile462Val以及CYP2E1基因-1239G>C位点的基因型。以比值比(OR)及其95%可信区间(CI)比较不同基因型与胃癌发病风险的相关关系。结果:与CYP1A1 462 Ile/Ile基因型携带者相比,462 Val/Val基因型携带者胃癌发病风险显著降低,其OR值分别为0.31 (95% CI: 0.16 ? 0.60;P = 0.001)。吸烟分层分析显示,在吸烟人群中,至少携带一个462Val等位基因的基因者与未携带者相比,发生胃癌的风险显著降低了59% (OR = 0.41, 95%CI = 0.24 ? 1.43;P = 0.001);且这种保护作用在重度吸烟患者中尤为明显(OR = 0.29, 95% CI = 0.14 ? 0.64;P = 0.002)。而CYP2E1-1239G>C各基因型分布在正常人群和胃癌患者中差异无统计学意义(P >0.05)。CYP1A1基因Ile462Val变异是影响胃癌易感性的重要因素。 Objective: To investigate the association of CYP1A1 Ile462Val and CYP2E1-1239G>C polymor-phisms with gastric cancer (GC) in Chinese population. Methods: The study included 230 cases with GC and 460 frequency-matched controls. The polymerase chain reaction-restriction frag-ment length polymorphism (PCR-RFLP) method was used to analyze genotype CYP1A1 Ile462Val and CYP2E1-1239G>C polymorphisms. The odds ratios (OR) and 95% confidence intervals (CI) were calculated using unconditional logistic regression model. Results: Compared with the CYP1A1 462 Ile/Ile genotype carriers, the subjects with 462 Val/Val genotype carriers have de-creased risk for gastric cancer, with the 0.31 of OR and 0.16 - 0.60 of 95% CI. When stratified by smoking status, subjects with at least one 462Val allele carrier had a reduced risk of developing GC (OR = 0.29, 95% CI = 0.14 - 0.64) among heavy smokers, but not among non-smokers. There was no significant difference in CYP2E1-1239G>C genotype distribution between gastric cancer cases and the control. Conclusion: CYP1A1 Ile462Val polymorphism is associated with the sus-ceptibility to GC in Chinese population.
出处 《亚洲肿瘤科病例研究》 2016年第4期72-78,共7页 Asian Case Reports in Oncology
  • 相关文献

参考文献2

二级参考文献49

  • 1Sun M,Sakakibara H,Ashida H,et al. Cytochrome P4501 A1-inhibitory action of antimutagenic anthraquinones in medicinal plants and the structure-activity relationship. Biosci Biotechnol Biochem,2000,64 (7):1373-1378.
  • 2Stephenson PU,Bonnesen C,Bjeldanes LF,et al. Modulation of cytochrome P4501A1 activity by ascorbigen in murine hepatoma cells.Biochem Pharmacol, 1999,58(7):1145-1153.
  • 3Inouye K,Mae T, Kondo S,et al. Inhibitory effects of vitamin A and vitamin K on rat cytochrome P4501A1-dependent monooxygenase activity. Biochem Biophys Res Commun, 1999,262(2):565-569.
  • 4Iba MM, Fung J. Induction of pulmonary cytochrome P4501A1: interactive effects of nicotine and mecamylamine. Eur J Pharmacol,1999,383 (3):399-403.
  • 5Cho IJ,Kim SG. Oltipraz inhibits 3-methylcholanthrene induction of CYP1A1 by CCAAT/enhencer-binding protein activation. J Biol Chem, 2003,278 (45):44103-44112.
  • 6Gabelova A, Bacova G, R uzekova L, et al. Role of cytochrome P4501A1 in biotransformation of a tissue specific sarcomagen N-methyldibenzo [c,g]carbazole. Mutat Res,2000,469(2): 259-269.
  • 7Greene JF, Zheng J, Grant DF, et al. C ytotoxicity of 1,2-epoxynaphthalene is correlated with protein binding and in situ glutathione depletion in cytochrome P4501A1 expressing Sf-21 cells. Toxicol Sci,2000,53(2):352-360.
  • 8Crofts F, Cosma GN, Currie D, et al. A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis. 1993, 14 (9): 1729- 1731.
  • 9Kao SY,Wu CH,Lin SC,et al. Genetic polymorphism of cytochrome P4501A1 and susceptibility to oral squamous cell carcinoma and oral precancer lesions assooiated with smoking/betel use. J Oral Pathol Med,2002,31(9):505-511.
  • 10Wu MT, Lee JM, Wu DC,et al. Genetic polymorphisms of cytochrome P4501A1 and oesophageal squamous-cell carcinoma in Tsawan. Br J Cancer,2002, 87(5):529-532.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部